GLP1 agonists are a very important management option- GPs who have not yet used this class of medications should learn more and start

They are potent in lowering blood glucose levels and weight. Given once a week and have non-glycaemic cardiovascular benefits

There are few contraindications and can be used in patients with very low eGFR

GLP1 agonists can be used as second-line after metformin, third line and some can also be used with insulin

 

Host: Dr David Lim | Total time: 38 mins

Guest: A/Prof Neale Cohen, Endocrinologist; Director of Clinical Diabetes, the Baker Heart and Diabetes Institute, Melbourne

 

Register for our fortnightly FREE WEBCASTS

Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

See omnystudio.com/listener for privacy information.